CDMO News

SGD Pharma Invests €20M in Green Packaging Facilities

  • SGD Pharma has invested over €20 million to upgrade its Zhanjiang plant in China.
  • The upgrade includes a new furnace and improved facilities, aiming to reduce CO2 emissions by 35% in 2030 and 65% in 2040.
  • The plant now offers feeder coloration and a range of colored glass options, mainly for luxury beauty products.

SGD Pharma, a global leader in primary glass packaging for pharmaceutical and cosmetic products, has made a significant investment of over €20 million to upgrade its Zhanjiang plant in China. This upgrade includes a complete rebuild of its furnace and a comprehensive improvement of the plant’s facilities.

Listen to our recent interview with SGD Pharma’s CEO Olivier Rousseau about their strategy to lead decarbonisation of the glass industry:

The new furnace, designed using advanced technologies, allows the Zhanjiang plant to increase capacity, improve energy performance, and minimize energy consumption. This aligns with SGD Pharma’s environmental commitments and long-term decarbonization roadmap. The company aims to reduce CO2 emissions from 2020 levels by 35% in 2030 and by 65% in 2040.

In addition to the furnace rebuild, SGD Pharma has upgraded production lines and inspection equipment at the plant to improve glass quality and production flexibility. The plant now offers feeder coloration and a range of colored glass options to meet specific requirements, primarily for luxury beauty products.

Chunyan Zheng, Deputy General Manager at SGD Pharma Zhanjiang plant, said: “This significant investment allows us to improve the operational excellence of Zhanjiang plant making sure that we manufacture the best in quality to serve our customers worldwide. We are delighted with the improvements to our plant and are excited about the new features that we can now provide our customers.”

Frédéric Barbier, General Manager of SGD Pharma BU APAC, added: “SGD Pharma has been working with the Science Based Targets initiative (SBTi) on the reduction of CO2 emissions and has developed a 1.5°C decarbonization pathway and target validation. The Zhanjiang plant is a critical part of this ambitious decarbonization plan. It is fantastic to see our new furnace working in a way that helps us to not only increase productivity but also minimize environmental impact. This €20 million renovation project illustrates our sustained investment strategy, and ongoing commitment towards a more sustainable future.”

ELEARNING
Learn the essentials of successful biopharma outsourcing

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.

Sign up to our free weekly newsletter for all the latest contract manufacturing news.  Register here

ELEARNING

Learn the essentials of successful biopharma outsourcing

New eLearning course distils 100+ expert interviews into 10 engaging modules.

tick Overview of outsourcing trends 
tick Expert insights and case studies 
tick Helpful resources and quizzes

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.